Nanna Acquisition Gives Astellas Mitochondrial Expertise
Pays Up To $86m For Platform And R&D
Japanese firm pays cash plus milestones for UK specialist as it looks to integrate novel screening platform and gain know-how in mitochondrial modulators with potential applications.
